IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MDWD

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q2 2021
Cash & Equivalents4.801.069.1511.873.7933.907.7311.0516.99
Inventory4.093.842.692.853.211.961.991.201.40
Total Current Assets59.9643.0852.1649.7037.3145.8416.8114.9521.52
Total Non-current Assets26.2923.9221.3316.7619.984.184.304.794.68
Total Assets86.2667.0073.5066.4657.3050.0221.1119.7426.20
Total Current Liabilities25.7129.0726.5410.8322.6112.0610.4210.729.66
Total Non-current Liabilities16.9217.8115.8024.0416.8227.0512.9313.6114.43
Total Liabilities*42.6246.8842.3434.8639.4339.1023.3424.3324.09
Retained Earnings(228.92)(219.09)(205.05)(174.82)(190.86)(168.11)(156.45)(148.51)(141.00)
Total Stockholder Equity43.6320.1231.1531.6017.8710.91(2.23)(4.58)2.12
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2023Q2 2022Q2 2021
Total Revenue5.715.064.676.06
Cost of Revenue*4.374.623.563.70
Gross Profit1.340.451.112.36
Research & Development3.491.902.192.66
Selling, General & Admin2.111.811.351.75
Total Operating Expenses7.064.934.795.26
Operating Income(5.72)(4.48)(3.67)(2.89)
Pretax Income(13.28)(6.31)(4.35)(3.18)
Tax Provision0.04-0.000.000.02
Net Income(13.32)(6.30)(4.35)(3.19)
Basic EPS(1.23)(0.68)----
Diluted EPS(1.23)(0.68)(0.13)--
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2023Q2 2022Q2 2021
Operating Cash Flow(5.76)(3.62)(5.25)(0.98)
Financing Cash Flow0.55(0.10)(0.73)(0.17)
← Scroll for more columns →